v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Cash Flows from Operating Activities        
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $ (53,880,914) $ (171,362,248) $ (172,678,759) $ (235,355,627)
Adjustments to reconcile net loss to net cash used in operating activities:        
Stock-based compensation     42,272,019 15,609,276
Revaluation of warrants and derivative liabilities (98,247,063) (3,622,758) (63,617,277) 3,106,223
Loss on exchange of warrants 57,770,454 0 57,770,454 0
Other financing costs - initial recognition of warrants     37,184,192 0
Amortization of debt discount and other non-cash interest expense     24,026,629 0
Depreciation and amortization     9,519,559 14,310,450
Gain on extinguishment of debt 0 (34,625) (1,553,771) (34,625)
Write-down of inventory to net realizable value 800,000 0 838,765 0
Impairment of intangible assets 12,006,452 73,447,067 12,006,452 73,447,067
Impairment of goodwill 0 28,846,832 0 28,846,832
Impairment of right-of -use assets 0 3,167,608 0 3,167,608
Deferred income taxes     0 (3,891,300)
Non-cash interest and other operating activities     0 216,021
Loss/(gain) on assets disposal     0 323,865
Changes in operating assets and liabilities:        
Accounts receivable     124,295 671,750
Inventories     (1,619,016) (16,154,711)
Prepaids and other assets     2,998,265 (726,490)
Accounts payable     9,025,613 9,523,141
Accrued expenses and other liabilities     (3,772,295) (77,010)
Right-of-use assets and lease liabilities     (1,112,981) (1,455,446)
Net cash used in operating activities     (48,587,856) (108,472,976)
Cash Flows from Investing Activities        
Purchase of equipment     (3,860,723) (12,470,001)
Net cash used in investing activities     (3,860,723) (12,470,001)
Cash Flows from Financing Activities        
Proceeds from issuance of notes payable with detachable warrants     33,003,225 0
Proceeds from issuance of notes payable by subsidiary     10,000,000 0
Payment of notes payable     0 (4,945,832)
Issuance of stock under equity line of credit     1,017,135 0
Net cash provided by financing activities     44,020,360 (4,945,832)
Change in cash     (8,428,219) (125,888,809)
Cash and restricted cash (in amount of $426,851), beginning of period     10,748,678 155,696,470
Cash and restricted cash (in amount of $915,751), ending of period $ 2,320,459 $ 29,807,661 2,320,459 29,807,661
Supplemental disclosure of Cash Flow information:        
Cash paid for interest     625,000 37,458
Supplemental Disclosure for Non-Cash Activities:        
Exercise of warrants recognized earlier as liabilities     45,990,081 59,163,019
Reclassification of property, plant and equipment to noncurrent assets held for sale due to settlement     45,175,558 0
Change in noncontrolling interest upon additional investments into subsidiary     1,863,420 0
Right-of-use assets obtained in exchange of operating lease liabilities     0 11,185,901
Conversion of Notes and Interest to Common Stock [Member]        
Supplemental Disclosure for Non-Cash Activities:        
Convertible notes and interest - conversion to common stock     26,291,423 0
Conversion of Debt and Interest into Common Stock [Member]        
Supplemental Disclosure for Non-Cash Activities:        
Extinguishment of debt and interest (in exchange for own common stock)     $ 4,553,771 $ 0